Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
167.33
+2.59 (1.57%)
At close: Aug 1, 2025, 4:00 PM
167.25
-0.08 (-0.05%)
After-hours: Aug 1, 2025, 7:59 PM EDT

Company Description

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use.

The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke.

This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery.

It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics.

The company was founded in 1886 and is based in New Brunswick, New Jersey.

Johnson & Johnson
Johnson & Johnson logo
CountryUnited States
Founded1886
IPO DateSep 24, 1944
IndustryDrug Manufacturers - General
SectorHealthcare
Employees138,100
CEOJoaquin Duato

Contact Details

Address:
One Johnson & Johnson Plaza
New Brunswick, New Jersey 08933
United States
Phone732 524 0400
Websitejnj.com

Stock Details

Ticker SymbolJNJ
ExchangeNYSE
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
CIK Code0000200406
CUSIP Number478160104
ISIN NumberUS4781601046
Employer ID22-1024240
SIC Code2834

Key Executives

NamePosition
Joaquin DuatoChief Executive Officer and Chairman
Joseph J. Wolk CPAExecutive Vice President and Chief Financial Officer
Jennifer L. TaubertExecutive Vice President and Worldwide Chairman of Innovative Medicine
Dr. John C. Reed M.D., Ph.D.Executive Vice President of Innovative Medicine, Research & Development
Timothy SchmidExecutive Vice President and Worldwide Chairman of MedTech
Robert J. Decker Jr.Controller and Chief Accounting Officer
James SwansonExecutive Vice President and Chief Information Officer
Darren SnellgroveVice President of Investor Relations
Dirk BrinckmanChief Compliance Officer
Elizabeth Forminard J.D.Executive Vice President and Chief Legal Officer

Latest SEC Filings

DateTypeTitle
Jul 24, 202510-QQuarterly Report
Jul 22, 202513F-HRQuarterly report filed by institutional managers, holdings
Jul 17, 2025144Filing
Jul 16, 20258-KCurrent Report
Jun 24, 202511-KAnnual report of employee stock purchase, savings and similar plans
Jun 24, 202511-KAnnual report of employee stock purchase, savings and similar plans
Jun 10, 20258-KCurrent Report
May 28, 2025SDForm - SD
May 7, 202513F-HRQuarterly report filed by institutional managers, holdings
May 2, 2025UPLOADFiling